These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24346355)

  • 1. Patients with risk factors have higher plasma levels of lysophosphatidic acid: a promising surrogate marker for blood platelet activation.
    Yao CS; Yan SG; Gao LS; Sun ZR; Liu F; Jiang B; Wang HB; Wu QZ
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):322-5. PubMed ID: 24346355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of acetylsalicylate on plasma lysophosphatidic acid level in patients with ischemic cerebral vascular diseases.
    Li ZG; Yu ZC; Wang DZ; Ju WP; Zhan X; Wu QZ; Wu XJ; Cong HM; Man HH
    Neurol Res; 2008 May; 30(4):366-9. PubMed ID: 18544253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome.
    Kurano M; Suzuki A; Inoue A; Tokuhara Y; Kano K; Matsumoto H; Igarashi K; Ohkawa R; Nakamura K; Dohi T; Miyauchi K; Daida H; Tsukamoto K; Ikeda H; Aoki J; Yatomi Y
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):463-70. PubMed ID: 25425621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
    Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
    Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome.
    Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Kurano M; Kishimoto T; Yanagisawa N; Ogita M; Miyazaki T; Nishino A; Yaginuma K; Tamura H; Kojima T; Yokoyama K; Kurata T; Shimada K; Daida H; Yatomi Y
    Atherosclerosis; 2013 Jul; 229(1):192-7. PubMed ID: 23664202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bioactive phospholipid lysophosphatidic acid is released from activated platelets.
    Eichholtz T; Jalink K; Fahrenfort I; Moolenaar WH
    Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):677-80. PubMed ID: 8489494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
    Nadar S; Blann AD; Lip GY
    Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
    Sandmann G; Siess W; Essler M
    Eur J Med Res; 2003 Sep; 8(9):397-404. PubMed ID: 14555295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome.
    Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Kishimoto T; Miyazaki T; Nishino A; Nakajima N; Yaginuma K; Tamura H; Kojima T; Yokoyama K; Kurata T; Shimada K; Yatomi Y; Daida H
    Clin Chim Acta; 2012 Jan; 413(1-2):207-12. PubMed ID: 21983165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway.
    Pamuklar Z; Lee JS; Cheng HY; Panchatcharam M; Steinhubl S; Morris AJ; Charnigo R; Smyth SS
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):555-61. PubMed ID: 18202325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lysophosphatidic acid is produced through diverse phospholipase pathways.
    Aoki J; Taira A; Takanezawa Y; Kishi Y; Hama K; Kishimoto T; Mizuno K; Saku K; Taguchi R; Arai H
    J Biol Chem; 2002 Dec; 277(50):48737-44. PubMed ID: 12354767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of plasma lysophosphatidic acid levels in ovarian cancer patients: A case-control study and updated meta-analysis.
    Cao L; Zhang Y; Fu Z; Dong L; Yang S; Meng W; Li Y; Zhang W; Zhang J; Zheng C; Zhu H; Fan L
    J Obstet Gynaecol Res; 2015 Dec; 41(12):1951-8. PubMed ID: 26472266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activation of human platelets by lysophosphatidic acid and adrenaline.
    Nilsson U; Svensson SP; Grenegård M
    Haematologica; 2002 Jul; 87(7):730-9; discussion 739. PubMed ID: 12091124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
    Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid level and the incidence of silent brain infarction in patients with nonvalvular atrial fibrillation.
    Li ZG; Yu ZC; Yu YP; Ju WP; Wang DZ; Zhan X; Wu XJ; Zhou L
    Int J Mol Sci; 2010 Oct; 11(10):3988-98. PubMed ID: 21152315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant association between lower pulse pressure and increasing levels of a novel type of phospholipid.
    Yao CS; Wu QZ; Xu HX; Liu F; Chang LG; Song LC; Gao LS; Meng XL
    Genet Mol Res; 2014 Feb; 13(2):2922-30. PubMed ID: 24634302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer.
    Sedláková I; Vávrová J; Tošner J; Hanousek L
    Tumour Biol; 2011 Apr; 32(2):311-6. PubMed ID: 21061112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.